With a brand value of USD $19.985 billion, Pfizer is the highest-ranking company in the Best Pharma Brands report. Headquartered in New York City, Pfizer is one of the world’s largest biopharmaceutical brands.
Pfizer’s corporate brand exerts an above average influence in driving choice for healthcare professionals (HCPs). Pfizer’s expertise extends to a number of therapeutic categories including immunology and inflammation, cardiovascular and metabolic diseases, oncology, vaccines, neuroscience and pain, and rare disease. HCPs believe that this breadth of expertise across therapeutic areas drives Pfizer's ability to deliver a broad array of healthcare solutions that exceed expectations. Pfizer’s global presence and legacy of dependability earned the company an impressive overall Brand Strength score, which exceeds that of its peers.
In November 2015, Pfizer entered into a definitive merger agreement that will combine the company with Allergan. How the merger of these two biopharmaceutical companies unfolds—and its impact on Pfizer’s brand—will be worth monitoring throughout 2016.
* After the launch of Best Pharma Brands on March 30, 2016, the merger between Pfizer and Allergan, Plc, was terminated by mutual agreement on April 6, 2016.